Cargando…
Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy
OBJECTIVE: Pandemics like coronavirus disease 2019 (COVID-19) bring along many individual and social problems. We aimed to investigate what changes the COVID-19 pandemic can cause in patients with epilepsy on drug compliance and stigmatization. MATERIAL AND METHOD: Modified Morisky Scale (MMS) and s...
Autores principales: | Gul, Zeynep Bastug, Atakli, Hayrunisa Dilek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685058/ https://www.ncbi.nlm.nih.gov/pubmed/33243679 http://dx.doi.org/10.1016/j.yebeh.2020.107610 |
Ejemplares similares
-
Depression and sexual functions in epilepsy patients: Comparison before and during the COVID-19 pandemic
por: Gul, Zeynep Bastug
Publicado: (2022) -
COVID-19: Facts, Cultural Considerations, and Risk of Stigmatization
por: Bruns, Debra Pettit, et al.
Publicado: (2020) -
The changes in smoking stigmatization during the COVID-19 pandemic
por: Jung, A-Reum, et al.
Publicado: (2023) -
Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy
por: Aksoy, Duygu, et al.
Publicado: (2016) -
Whether the Presence of Depressions Increases Stigmatization of People with Epilepsy?
por: Suljic, Enra, et al.
Publicado: (2018)